Hepatic FXR/SHP axis modulates systemic glucose and fatty acid homeostasis in aged mice

Cited by (107)

Items 101–107 of 107

1. Mechanism for FXR to regulate bile acid and glycolipid metabolism to improve NAFLD
   Zhi Guo Huang, Rongrong Zhou · 2023 · World Chinese Journal of Digestology
2. The mechanism of effective components compatibility of Astragalus and Nelumbinis folium on the prevention and treatment of dyslipidemia by regulating cholesterol reversal transport
   Jian Chen, Shi Cheng, Yufang Zhang, Ya Gao, Dantong Li, Ying Gu, Yixin Zhang, Muqing Zhang · 2023 · Research Square
3. Nuclear receptors in age-related diseases: From mechanisms to drug discovery
   Lijun Zhang, Xiangyi Li, Chanjuan Ren, Yumeng Hao, Yanyan Deng, Hui Pan, Young-Bum Kim, Shengjie Fan, Cheng Huang, Guang‐Bo Ge et al. · 2026 · Ageing Research Reviews
4. Farnesoid x Receptor Deficiency Promotes Hepatocytic Injury in Cyp2c70 ‐Deficient Mice With a Human‐Like Bile Acid Composition
   Hilde D. de Vries, Jinxiao Li, Kirill Ustyantsev, Milaine V. Hovingh, Niels L. Mulder, Rick Havinga, Anna Palmiotti, Krisztina de Bruyn, Brecht J. Attema, Ellen Weersing et al. · 2026 · Liver International
5. The effect of artificial intelligence-driven, computed tomography-based assessment of body composition parameters on 28-day mortality of patients with severe fever with thrombocytopenia syndrome: a retrospective cohort study
   Fan Yang, Shiyu Zhang, Shuting Liu, Jianfeng Zhang, Jinrong Yang, Dilihumaer Zhayier, Gao Ruihan, Fan Pu, Minfeng Xu, Bin Zhu et al. · 2026 · BMC Infectious Diseases
6. BindingDB Entry 50019684: Discovery of the First-in-Class Intestinal Restricted FXR and FABP1 Dual Modulator ZLY28 for the Treatment of Nonalcoholic Fatty Liver Disease.
   BindingDB · 2024 · UC San Diego
7. SU5, a Stable Auraptene Analog, Ameliorates Metabolic Dysfunction‐Associated Steatohepatitis Through Modulation of the FXR Signaling Pathway
   Fen Wen, Jing Chen, Lei Zhu, Siyu Xia, Yang Huang, Dezhi Bian · 2026 · Drug Development Research